Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pentail Enzymes

Pentail Enzymes
Accelerator/Inc LATEST DEAL TYPE

Owner and operator of a biotechnology company created to harness the power of enzymes to improve human health. The company's prototype enzymes are being developed to neutralize a range of misused drugs, including prescription and over-the-counter medicines, which when overdosed can often lead to death or permanent organ damage, enabling drug companies to have access to enzymes that target harmful substances in the human body for rapid elimination, ultimately helping to save lives.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • Cambridge
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pentail Enzymes’s full profile, request a free trial.

Pentail Enzymes Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Pentail Enzymes Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Accelerate Cambridge Accelerator/Incubator Minority 000 0000 000000 0